Teo Forcht Dagi is a neurosurgeon and venture capitalist with an abiding interest in biomedical innovation and translational science. He holds professorial appointments in Neurosurgery at the Mayo Alix College of Medicine and Science, and at Queen’s University Belfast in Northern Ireland, where he previously chaired the faculty of medicine and the William J. Clinton Leadership Institute. He also serves as an International Surgical Advisor for the United States and Member of the Surgical Specialty Board for Neurosurgery at the Royal College of Surgeons of Edinburgh. Previously, he served as CEO of Boston Neurosciences, Inc., as a partner in several venture capital groups, and director of a number of privately held and publicly listed biomedical companies in the UK, Canada and the US. He is currently a Senior Managing Partner with ROSC Global, LLC. He was a director of the Harvard-MIT Program in Biomedical Entrepreneurship, of the Goergen Entrepreneurial Institute at Wharton, and at the Georgia Institute of Technology. He has advised a number of academic and research institutions and sovereign wealth entities on innovation policy, practice and investment and is currently senior advisor to CURAM, the program in medical device development for the National University of Ireland in Galway. He also advises the Leducq Foundation, a venture philanthropy group focused on cardiovascular and neurovascular innovations. Teo received an AB from Columbia College, MD and MPH from Johns Hopkins, MTS from Harvard and MBA from Wharton and trained in Neurosurgery at the Massachusetts General Hospital and at the Neurosurgical Unit of the Maudsley, Guy’s and King’s College Hospitals in London. He served as a flight surgeon and neurosurgeon in the US military and is currently the Deputy Command Surgeon of the Georgia State Defense Force.